Cyclin-dependent kinase 12, immunity, and prostate cancer

Emmanuel Antonarakis

doi:10.1056/NEJMcibr1808772

Cyclin-dependent kinase 12, immunity, and prostate cancer

Emmanuel Antonarakis

School of Medicine

Research output: Contribution to journal › Article › peer-review

27 Scopus citations

Original language	English (US)
Pages (from-to)	1087-1089
Number of pages	3
Journal	New England Journal of Medicine
Volume	379
Issue number	11
DOIs	https://doi.org/10.1056/NEJMcibr1808772
State	Published - Sep 13 2018

ASJC Scopus subject areas

General Medicine

Access to Document

10.1056/NEJMcibr1808772

Cite this

@article{be76aefbb39045ca97098f4ba8915f06,

title = "Cyclin-dependent kinase 12, immunity, and prostate cancer",

author = "Emmanuel Antonarakis",

year = "2018",

month = sep,

day = "13",

doi = "10.1056/NEJMcibr1808772",

language = "English (US)",

volume = "379",

pages = "1087--1089",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "11",

}

TY - JOUR

T1 - Cyclin-dependent kinase 12, immunity, and prostate cancer

AU - Antonarakis, Emmanuel

PY - 2018/9/13

Y1 - 2018/9/13

UR - http://www.scopus.com/inward/record.url?scp=85053482893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053482893&partnerID=8YFLogxK

U2 - 10.1056/NEJMcibr1808772

DO - 10.1056/NEJMcibr1808772

M3 - Article

C2 - 30207914

AN - SCOPUS:85053482893

SN - 0028-4793

VL - 379

SP - 1087

EP - 1089

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 11

ER -

Cyclin-dependent kinase 12, immunity, and prostate cancer

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this